BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SCM Strengthens Quality Team


1/8/2013 11:13:13 AM

January 2013 -- CONTRACT development and manufacturing organisation (CDMO) SCM Pharma has bolstered its quality department and board with the appointment of a new Qualified Person (QP).

Senior quality professional Mark Edwards joins the UK-based company as Quality Assurance Director to manage the QC function and be responsible for quality across the organisation’s three sites.

Highly-experienced Mark has spent over 30 years in the global pharmaceutical and biotech industry having worked with the likes of Merck, Abbot and Fujifilm and becomes the third QP at SCM Pharma.

He brings extensive knowledge of quality systems, a variety of different dosage forms, production management and the undertaking of the preparation for pre-approval inspections and other regulatory authorities to his new role.

Dianne Sharp, managing director at SCM Pharma, said: “There are hugely important quality requirements around the sterile manufacturing and filling of drugs so we need to always ensure we have the right level of expertise and resource to meet the regulatory requirements.

“At present, almost a third of our entire workforce sits within the quality function, which demonstrates our commitment to achieving the highest quality standards across our development, clinical trial supply and commercial production operations.

“Mark is an exceptional addition to our board of directors given his background in quality and will bring a great deal to our clients’ projects in terms of ensuring quality systems are robust, manufactured products are fit for purpose and the efficient release of products.”

The CDMO specialises in the sterile production of products for clinical trials along with the supply of licensed drugs in niche markets. It is currently gearing up for the opening of its new commercial facility that will reinforce its expertise in vial, ampoule and syringe filling, particularly when dealing with highly potent and toxic products that require aseptic processing using isolator technology.

SCM Pharma’s newly appointed quality assurance director Mark Edwards said: “I am delighted to be joining such a dynamic and reputable manufacturer such as SCM Pharma. I’ve worked with many pharma companies over the years and my aim here is to develop quality metrics so they help drive the right behaviour that supports the business in its delivery of finished products.

“I am looking forward to the challenge of simplifying systems whilst remaining compliant but at the same time making them more efficient and future proofing them to withstand increasing volumes and up and coming legislation.

“Already I’ve been really impressed by the can-do attitude from the staff along with a complete package of development work through to the to commercial manufacture of finished dosage forms including terminally sterilised and aseptically filled products.”

A QP since 1992, Mark has undertaken a Post Graduate Diploma in Industrial Pharmaceutical studies at Brighton University, Mark is also a Graduate of the Society of Biology specialising in Microbiology from the North East Surrey College of Technology and a Fellow of the Institute of Biomedical Sciences from Paddington College, London.



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES